EGFR and neoplasm: Immunohistochemical examination (pre- and post-treatment biopsies) of tumor tissues/metastases after CAR-T cell infusion showed enrichment of CD3 + cells and reduction of EGFR + tumor cells, suggesting that anti-EGFR CAR-T cells may have reached tumor tissues and may be associated with elimination of EGFR-expressing tumor cells.